Repro-Med Systems, Inc. (NASDAQ:REPR) Director Joseph M. Jr. Manko purchased 136,248 shares of the company’s stock in a transaction dated Friday, September 30th. The stock was bought at an average cost of $0.44 per share, for a total transaction of $59,949.12. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Repro-Med Systems, Inc. (NASDAQ:REPR) opened at 0.445 on Friday. The firm has a market capitalization of $16.89 million and a P/E ratio of 37.083. The stock has a 50 day moving average of $0.41 and a 200-day moving average of $0.38. Repro-Med Systems, Inc. has a 1-year low of $0.28 and a 1-year high of $0.59.

Insider Buying and Selling by Quarter for Repro-Med Systems (NASDAQ:REPR)

Repro-Med Systems Company Profile

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

5 Day Chart for NASDAQ:REPR

Receive News & Ratings for Repro-Med Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems Inc. and related companies with's FREE daily email newsletter.